Log in
NYSE:MTL

Mechel PAO Stock Forecast, Price & News

$1.47
-0.05 (-3.29 %)
(As of 10/23/2020 12:00 AM ET)
Add
Compare
Today's Range
$1.47
Now: $1.47
$1.52
50-Day Range
$1.40
MA: $1.52
$1.67
52-Week Range
$1.28
Now: $1.47
$3.43
Volume38,800 shs
Average Volume129,052 shs
Market Capitalization$305.96 million
P/E RatioN/A
Dividend YieldN/A
Beta1.14
Mechel PAO, together with its subsidiaries, engages in mining, steel, and power businesses in Russia, Asia, Europe, the Commonwealth of Independent States, the Middle East, the United States, and internationally. Its Mining segment produces and sells coking, metallurgical, and steam coal; coke; chemical products, including coal tar, coal benzene, and other compounds; and iron ore and iron ore concentrates. The company's Steel segment produces and sells semi-finished steel products, long steel products, and carbon and stainless flat products; ferrosilicon products; and pig iron, as well as metal products, including wire products, stampings and forgings, structural shapes, beams, and rails. Its Power segment generates and supplies electricity, heat energy, and other power resources to third parties. Mechel PAO also offers sea, rail, and motor transportation logistics services to third parties. The company was formerly known as Mechel OAO and changed its name to Mechel PAO in March 2016. Mechel PAO was founded in 2003 and is based in Moscow, Russia.
Read More
Mechel PAO logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.36 out of 5 stars

Industry, Sector and Symbol

Industry Blast furnaces & steel mills
Sub-IndustryN/A
CUSIPN/A
Phone7-495-221-8888
Employees56,182

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$4.60 billion
Cash Flow$1.32 per share
Book Value($14.55) per share

Profitability

Miscellaneous

Market Cap$305.96 million
Next Earnings DateN/A
OptionableOptionable
$1.47
-0.05 (-3.29 %)
(As of 10/23/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive MTL News and Ratings via Email

Sign-up to receive the latest news and ratings for MTL and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Mechel PAO (NYSE:MTL) Frequently Asked Questions

How has Mechel PAO's stock price been impacted by COVID-19?

Mechel PAO's stock was trading at $1.91 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, MTL shares have decreased by 23.0% and is now trading at $1.47.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Mechel PAO?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Mechel PAO in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Mechel PAO
.

What price target have analysts set for MTL?

1 equities research analysts have issued 12 month target prices for Mechel PAO's stock. Their forecasts range from $8.50 to $8.50. On average, they expect Mechel PAO's stock price to reach $8.50 in the next twelve months. This suggests a possible upside of 478.2% from the stock's current price.
View analysts' price targets for Mechel PAO
.

Are investors shorting Mechel PAO?

Mechel PAO saw a increase in short interest during the month of September. As of September 15th, there was short interest totaling 97,500 shares, an increase of 23.1% from the August 31st total of 79,200 shares. Based on an average daily trading volume, of 61,100 shares, the days-to-cover ratio is currently 1.6 days.
View Mechel PAO's Short Interest
.

Who are some of Mechel PAO's key competitors?

What other stocks do shareholders of Mechel PAO own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Mechel PAO investors own include Micron Technology (MU), Matinas BioPharma (MTNB), SCYNEXIS (SCYX), B2Gold (BTG), Callon Petroleum (CPE), Flexion Therapeutics (FLXN), Intel (INTC), Intec Pharma (NTEC), SSR Mining (SSRM) and AbbVie (ABBV).

Who are Mechel PAO's key executives?

Mechel PAO's management team includes the following people:
  • Mr. Oleg Viktorovich Korzhov, Chairman of the Management Board, CEO & Director (Age 50)
  • Ms. Nelli Rafailovna Galeeva, Deputy CEO for Economics & Fin. and Member of Management Board (Age 47)
  • Ms. Irina Nikolaevna Ipeeva, Deputy CEO for Legal Affairs, Member of Management Board & Director (Age 57)
  • Mr. Victor Alexandrovich Trigubko, Sr. VP of Gov. Relations, Member of Management Board & Director (Age 64)
  • Mr. Valery Anatolievich Sheverdin, Deputy CEO & Member of Management Board (Age 57)

What is Mechel PAO's stock symbol?

Mechel PAO trades on the New York Stock Exchange (NYSE) under the ticker symbol "MTL."

Who are Mechel PAO's major shareholders?

Mechel PAO's stock is owned by a number of institutional and retail investors. Top institutional investors include Ritholtz Wealth Management (0.03%).

Which institutional investors are selling Mechel PAO stock?

MTL stock was sold by a variety of institutional investors in the last quarter, including Ritholtz Wealth Management.

How do I buy shares of Mechel PAO?

Shares of MTL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Mechel PAO's stock price today?

One share of MTL stock can currently be purchased for approximately $1.47.

How big of a company is Mechel PAO?

Mechel PAO has a market capitalization of $305.96 million and generates $4.60 billion in revenue each year. Mechel PAO employs 56,182 workers across the globe.

What is Mechel PAO's official website?

The official website for Mechel PAO is www.mechel.ru.

How can I contact Mechel PAO?

Mechel PAO's mailing address is KRASNOARMEYSKAYA STREET 1, MOSCOW 1Z, 125167. The basic materials company can be reached via phone at 7-495-221-8888 or via email at [email protected]

This page was last updated on 10/26/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.